Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. A positive screening test for an untreatable condition provides psychological relief from uncertainty

letter

. 1995 Jul 1;311(6996):58–59. doi: 10.1136/bmj.311.6996.58c

Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. A positive screening test for an untreatable condition provides psychological relief from uncertainty.

PMCID: PMC2550111 PMID: 7646731

These references are in PubMed. This may not be the complete list of references from this article.

Lynch H. T., Watson P., Conway T. A., Lynch J. F., Slominski-Caster S. M., Narod S. A., Feunteun J., Lenoir G. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. Arch Intern Med. 1993 Sep 13;153(17):1979–1987. [PubMed] [Google Scholar]
Ryan M. P., French J., al-Mahdawi S., Nihoyannopoulos P., Cleland J. G., Oakley C. M., Harper P. S., Clarke A., Davis J., Grigg L. Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. BMJ. 1995 Apr 1;310(6983):856–859. doi: 10.1136/bmj.310.6983.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
Wiggins S., Whyte P., Huggins M., Adam S., Theilmann J., Bloch M., Sheps S. B., Schechter M. T., Hayden M. R. The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med. 1992 Nov 12;327(20):1401–1405. doi: 10.1056/NEJM199211123272001. [DOI] [PubMed] [Google Scholar]